Heart Failure Controversies
The prevalence of heart failure (HF) rises from 2% to 3% at age 65 to more than 50% in persons older than age 80. Many of these patients have HFPEF. The condition is not uncommon in elderly women, most of whom have hypertension, diabetes mellitus, or both and often coronary heart disease (CHD). However, CHD more commonly causes systolic heart failure (SHF). Atrial fibrillation is common in the elderly, and ventricular rates even when not very rapid (120-140) may precipitate HF with a preserved ejection fraction (EF).
KeywordsDiastolic Dysfunction Heart Failure Patient Angiotensin Receptor Blocker Constrictive Pericarditis Systolic Heart Failure
Unable to display preview. Download preview PDF.
- 3.ACC/AH A guidelines for the evaluation and management of chronic heart failure in the adult: Executive summary. J Am Coll Cardiol 2001;8:2101.Google Scholar
- 6.Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005guideline update for the diagnosis and management of chronic heart failure in the adult—summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol 2005;46:1116–1143.CrossRefGoogle Scholar
- 8.Meier-Ewert HK, Gaasch WH. What is diastolic heart failure and how do we treat it? ACC Curr J Rev Nov/Dec:52, 2001.Google Scholar
- 10.Khan M Gabriel. Cardiomyopathy. In: Heart Disease, Diagnosis and Therapy. Totowa, NJ, HumanaPress, 2005, pp. 443–470.Google Scholar
- 17.Pitt B, Remme W, Zannad F, et al. for the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study Investigators. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 2003;348:1309–1321.PubMedCrossRefGoogle Scholar
- 20.Jourdain P, Funck F, Gueffet P, et al. Benefits of BNP plasma levels for optimizing therapy: The Systolic Heart Failure Treatment supported by BNP multicenter randomised trial (STARS-BNP). (abstr) J Am Coll Cardiol 2005;45(Suppl A):3A.Google Scholar